ArticleNarra J2023

Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients.

Cut A Andra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.